Serena Travaglini

Dr. Serena Travaglini is a Principal Investigator and Researcher at the Laboratory of Biochemistry and Molecular Biology, University of Rome Tor Vergata. Her research focuses on characterizing leukemic stem cells in FLT3-ITD-positive acute myeloid leukemia (AML).

Her investigations identify therapeutic targets like CD99 and explore molecular mechanisms of leukemia progression. Recent publications analyze FLT3 mutation responses, metastasis pathways in extramedullary AML, and transcription factor regulation in leukemia differentiation. Her work employs molecular profiling, transcriptomic analysis, and functional characterization of leukemic precursors.